Image via CrunchBase
100,000 bottles of the pain medication Embeda were recalled due to a defect in the drug's formula. Pfizer Inc., the drug manufacturer, said in a statement that Embeda would not be available for months due to a stability defect in the extended-release product.
The pain medication contains naltrexone, an opiate antagonist drug, and did not meet degrading standards when tested by the manufacturer. Naltrexone discourages misuse and abuse of Embeda as naltrexone disintegrates when chewed or crushed.
According to a press release from the company, Embeda has been recalled from U.S. wholesalers and retailers, and patients may continue to take the medication as prescribed. All dosages of Embeda extended-release capsules may be subject to recall.